Centre de Référence Maladies Rares

U1035 INSERM

Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC)

FR: Biologie Fondamentale Appliquée à la Médecine

U1035Display navigation INSERM U1035! FR / EN

Sarah LESJEAN

Engineer AssistantIn charge of scientific mediation, communication and cultural projects., sarah.lesjean@inserm.fr

BIOSKETCH

PUBMED LINKEDIN

PATENTS

  • Use of Glypican-3-targeting microRNAs for treating liver cancer. EP 15 3061072 European patent UNIVERSITE DE BORDEAUX-INSERM
  • Use of catenin-beta 1-targeting microRNAs for treating liver cancer. EP 15 3061130 European patent UNIVERSITE DE BORDEAUX-INSERM-UNIVERSITE PARIS SUD - PARIS XI

Back to organigramme

INSERM U1035! - University of Bordeaux
Work
146 rue Léo Saignat - PE building south zone, 4th floor
33000 Bordeaux
Aquitaine
France
Work +33 557 57 13 73/74
sarah.lesjean@inserm.fr